Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baermed Research is a Swiss clinical research and education organization specializing in visceral surgery and regenerative medicine. Based in Zurich at the Hirslanden Clinic, the company focuses on advancing surgical techniques and therapeutic interventions for complex abdominal conditions, particularly those involving the liver and pancreas. Led by Prof. Dr. Hans U. Baer, the entity conducts translational research into liver regeneration and innovative treatments for pancreatic cancer. Baermed Research bridges the gap between high-end surgical practice and academic research, providing both clinical services and professional training. Their work is characterized by a commitment to improving patient outcomes through evidence-based surgical innovation and the exploration of cell-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baermed Research.